Dishman Carbogen Amcis Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 184.45 as of 12 Jun 15:30 . The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 1036 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Remedium Lifecare Ltd changed from 36.4 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 3411 crore on March 2025 to ₹ 3693 crore on March 2024 . This represents a CAGR of 1.60% over 5 yearsThe Market Cap of Remedium Lifecare Ltd changed from ₹ 73.38 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 867.82 crore as compare to the Dec '25 revenue of ₹ 726.46 crore. This represent the growth of 19.46% The revenue of Remedium Lifecare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 178.22 crore as compare to the Dec '25 ebitda of ₹ 119.77 crore. This represent the growth of 48.8% The ebitda of Remedium Lifecare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dishman Carbogen Amcis Ltd changed from ₹ -77.57 crore to ₹ 21.74 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
The name of Carbogen Amcis (India) Ltd.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Remedium Lifecare Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 2,891 Cr while Market cap of Remedium Lifecare Ltd is 24 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd?

As of June 15, 2026, the Dishman Carbogen Amcis Ltd stock price is INR ₹184.45. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.28.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.